Examination of the MASH1 gene in patients with Parkinson's disease.
Examination of the MASH1 gene in patients with Parkinson's disease.
复制标题
DOI:
10.1016/j.bbrc.2010.01.061
复制
发表时间:
2010-02
影响因子:
3.1
通讯作者:
H. Deng;Hua-rong Yang;W. Le;Xiong Deng;Hongbo Xu;W. Xiong;Shaihong Zhu;W. Xie;Zhi Song
中科院分区:
文献类型:
--
作者:
H. Deng;Hua-rong Yang;W. Le;Xiong Deng;Hongbo Xu;W. Xiong;Shaihong Zhu;W. Xie;Zhi Song
Several genetic variants in transcription factor genes have been reported to be associated with Parkinson’s disease (PD). The mammalian achaete-scute homolog 1 gene (MASH1) controls development of the locus coeruleus. Furthermore, polyglutamine length variation in MASH1 gene appears to confer protective effects against PD, at least in Japanese population. To determine whether genetic variation in the coding region of the MASH1 gene plays a role in the etiology of PD Caucasian patients, we analyzed the whole coding region of the MASH1 gene in PD patients from North America. Case-control analysis showed nominal association between polyglutamine length variation in MASH1 and Caucasian PD, 8% of PD vs 13% of normal controls had 13 CAG repeats (p=0.027, χ2=4.906). Our data support the role of the polyglutamine length variants in the MASH1 gene in PD susceptibility.